Metformin acetate

醋酸二甲双胍

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameMetformin acetate
Drug Alias NameAcetometHL-018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsObesityDiabetes MellitusPolycystic Kidney, Autosomal Dominant +[4] 
Global Approved IndicationsObesityDiabetes Mellitus
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2012/03/01
Country/TerritoryUnited StatesItalySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanall
China Registration ClassN/A

Develop Information

Active CompaniesHanallUniversity Of Colorado Denver
Inactive CompaniesTeva Pharmaceuticals Usa IncAzienda Ospedaliero-Universitaria Consorziale
Active IndicationsObesityDiabetes MellitusProstatic Neoplasms
Inactive IndicationsPolycystic Kidney, Autosomal Dominant

Other Information

ATC CodeA10BA02
Related LinksN/A